EUVIMED · CrossrefZeitschrift
Blood Vessels, Thrombosis & Hemostasis
ISSN 2950-3272 · Elsevier BV
Neueste Artikel
Seconds-resolved in vivo measurements reveal rapid, serotonin transporter–independent plasma serotonin clearance
The 2025 McMaster Immune Thrombocytopenia (ITP) Summit: insights from autoimmune hemolytic anemia
Low platelets, high stakes: pregnancy after a diagnosis of immune thrombocytopenia
Targeting plasma cells for treatment of immune thrombocytopenia
The molecular pathophysiology of immune thrombocytopenia: the new frontier
The platelet variability index as a diagnostic tool in immune thrombocytopenia: a cohort study from Mexico
Bruton’s tyrosine kinase inhibitors in primary immune thrombocytopenia: pathophysiology and clinical evidence
Safety and effectiveness of caplacizumab in pediatric patients with iTTP: real-world experience
Indium-labeled scintigraphy to predict splenectomy response in ITP: back to the future
Caplacizumab in children: confirm diagnosis, tailor dose
Identifying abnormalities in thrombin generation and platelet ATP release in bleeding disorder of unknown cause
Temporal activation of the contact coagulation pathway after endovascular treatments for acute ischemic stroke
Advanced Characterization of Thrombi from Stroke Patients Reveals Impact of Acute Viral Infection on Clot Composition
Von Willebrand factor/factor VIII (Wilate) prophylaxis in children aged
Defibrotide inhibits thrombin-dependent functions only at supratherapeutic concentrations
P-Selectin Inhibition Prevents Trauma-Induced Systemic Microvascular Obstruction in a Murine Model of Polytrauma
Venous Thromboembolism in Pregnant Patients with Sickle Cell Disease: A Single-Center Retrospective Analysis
Randomized Phase 2 Trial of Freeze-dried Platelets for Bleeding in Thrombocytopenic Patients Hematologic Malignancies
Development of autologous in vitro vascular models for use in preclinical biotherapeutic development
Murine thrombus organization limits access to high platelet activation states while supporting platelet recruitment
A case report of high-titer FVIII inhibitor development after AAV-mediated gene therapy in hemophilia A
The role of hemoglobin F in sickle cell disease complications: a descriptive secondary analysis
rFVIIIa-platelet binding enhances platelet procoagulant activity independently of thrombin generation
Alpelisib, a PI3Kα inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypes
A novel in vitro model of trauma-induced endotheliopathy provides a platform for studying mechanisms of coagulopathy
Ticagrelor promotes arterial healing and shows superiority to clopidogrel in preventing neoatherosclerosis
Bacterial infection and activation of the contact pathway of coagulation
Endo-chip laser-induced thrombus formation: a vessel-on-chip model for in vitro testing of antithrombotic agents
Procoagulant off-target effect of the direct oral anticoagulant reversal agent andexanet alfa
Recombinant ADAMTS-13 for congenital and immune thrombotic thrombocytopenic purpura in pregnancy
EUVIMED